dehydrocostus lactone has been researched along with Sepsis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, KC; Kim, HJ; Kwak, JH; Lee, DU; Park, EJ; Park, SW | 1 |
1 other study(ies) available for dehydrocostus lactone and Sepsis
Article | Year |
---|---|
Dehydrocostuslactone inhibits LPS-induced inflammation by p38MAPK-dependent induction of hemeoxygenase-1 in vitro and improves survival of mice in CLP-induced sepsis in vivo.
Topics: Animals; Anti-Inflammatory Agents; Cecum; Cell Line; Cell Survival; Dinoprostone; Gene Silencing; Heme Oxygenase-1; Lactones; Ligation; Lipopolysaccharides; Liver; Lung; Macrophages; Membrane Proteins; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Sepsis; Sesquiterpenes | 2014 |